ALEXANDRIA, Va.—The American Society of Clinical Oncology (ASCO) announced today that it is seeking applications for research grants for projects that use data from CancerLinQ Discovery®, an offering of ASCO's CancerLinQ® initiative, as a source. CancerLinQ Discovery® provides curated sets of de-identified data from cancer patients to academic researchers, government agencies, and others in the oncology community to generate practical knowledge that will improve cancer care.
"These research support grants provide investigators with a unique opportunity to explore unseen patterns in patient characteristics and outcomes using real-world data from CancerLinQ Discovery®," said ASCO Chief Medical Officer Richard L. Schilsky, MD, FACP, FSCT, FASCO. "The findings from their research have the potential to inform clinical practice and improve the quality of patient care."
CancerLinQ® collects and analyzes real-world data from patients at practices nationwide, drawing from electronic health records. The CancerLinQ Discovery® de-identified custom data sets are derived from the vast pool of data contributed by participating practices.
With grants of $32,500 each, ASCO will provide early and mid-career clinical oncology and health service investigators with real-world evidence that can inform their research. The grants—as many meritorious awards as funds permit—are being funded by the Mission Endowment of Conquer Cancer®, The ASCO Foundation. Each one-year grant covers the cost of the CancerLinQ Discovery® data set and a kickoff meeting at ASCO headquarters and contributes to personnel and/or research expenses.
Applicants are invited to submit research proposals consistent with ASCO's mission to conquer cancer through research, education, and promotion of the highest quality patient care that can be addressed using CancerLinQ Discovery® data. Research topics may include adoption of treatment guidelines across the U.S.; development of quality measures with the highest impact for clinical care; measuring the impact of educational programs on clinical practice; supportive evidence for informing ASCO policy priorities; or novel research on other topics.
The top proposals will be selected by a review panel and funded, and the grant recipients will be invited to ASCO headquarters for an initial training session on CancerLinQ Discovery®, as well as ongoing mentoring on the use of the database. Each recipient will be expected to publish their work in top-tier medical journals.
Applicants must meet the following criteria:
- Hold a doctoral degree (including but not limited to MD, DO, PharmD, or PhD)
- Have completed final subspecialty training after 2009 for a PhD or PharmD and 2014 for an MD or DO
- Be planning an investigative career in clinical oncology or health services research with a focus in oncology
- Have a mentor in the proposed research field at their respective institutions
- Not hold another active grant from Conquer Cancer, The ASCO Foundation
- Be an active ASCO member
- Be based in a U.S. practice or institution
- Be a U.S. Citizen or Permanent Resident.
The Request for Proposals (RFP) document will be available on or before March 1. Applications are due on April 30, 2019. Learn more about this opportunity and how to submit a research grant proposal.
Conquer Cancer Mission Endowment provides a long-term base of support to advance the foundation's critical mission to improve the care and treatment of people living with cancer. The endowment is the cornerstone of its efforts to extend the reach and impact of its work and allows Conquer Cancer to continue to support the very best opportunities for scientific research, professional development, and patient education well into the future. Mission Endowment provides a stable flow of funds to increase grant funding, sustain existing programs, develop new initiatives, and reach new audiences around the world.
CancerLinQ® and CancerLinQ Discovery® are projects of CancerLinQ LLC. For more information about either initiative, please go to www.CancerLinQ.org.
Founded in 1964, the American Society of Clinical Oncology, Inc. (ASCO®) is committed to making a world of difference in cancer care. As the world’s leading organization of its kind, ASCO represents nearly 45,000 oncology professionals who care for people living with cancer. Through research, education, and promotion of the highest-quality patient care, ASCO works to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy. ASCO is supported by its affiliate organization, the Conquer Cancer Foundation. Learn more at www.ASCO.org, explore patient education resources at www.Cancer.Net, and follow us on Facebook, Twitter, LinkedIn, and YouTube.
About CancerLinQ LLC
CancerLinQ LLC is a subsidiary of American Society of Clinical Oncology, Inc. established for the development and operation of the CancerLinQ® initiative. CancerLinQ® is a health information technology platform aimed at enhancing and improving the understanding and treatment of cancer. To learn more, visit www.cancerlinq.org.